Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A PROSPECTIVE, CONTROLLED, RANDOMIZED, OPEN-LABEL PREMARKET MULTICENTER STUDY OF THE PERFORMANCE OF THE HM242-GEL VS COMPARATOR IN PATIENTS UNDER THE CONDITION OF VENOUS LEG ULCER

NCT04902651 is registered in ClinicalTrials.gov with B. Braun Ltd. Centre of Excellence Infection Control as lead sponsor.

NCT NCT04902651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04902651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A PROSPECTIVE, CONTROLLED, RANDOMIZED, OPEN-LABEL PREMARKET MULTICENTER STUDY OF THE PERFORMANCE OF THE HM242-GEL VS COMPARATOR IN PATIENTS UNDER THE CONDITION OF VENOUS LEG ULCER
Lead sponsor
B. Braun Ltd. Centre of Excellence Infection Control
Phase
Not applicable
Overall status
Terminated
Start date
May 21, 2021
Completion date
February 16, 2022
Enrollment
73 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

venous leg ulcer